February 13, 2026 12:01 am (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
BJP MP files notice to cancel Rahul Gandhi's Lok Sabha membership, seeks life-long ban | Arrested in the morning, out by evening: Tycoon’s son walks free in Lamborghini crash case | ‘Why should you denigrate a section of society?’: Supreme Court pulls up ‘Ghooskhor Pandat’ makers | Bangladesh poll manifestos mirror India’s welfare schemes as BNP, Jamaat bet big on women, freebies | Drama ends: Pakistan makes U-turn on India boycott, to play T20 World Cup clash as per schedule | ‘Won’t allow any impediment in SIR’: Supreme Court pulls up Mamata govt over delay in sharing officers’ details | India-US trade deal: ‘Negotiations always two-way’, says Amul MD amid farmers’ concerns | Khamenei breaks 37-year-old ritual for first time amid escalating Iran-US tensions | India must push for energy independence amid global uncertainty: Vedanta chairman Anil Agarwal | Kanpur horror: Lamborghini driven by businessman’s son rams vehicles, injures six
COVI19 Antibodies
WIKIMEDIA COMMONS

Less than 10 percent of world’s population have developed coronavirus antibodies: WHO Chief Scientist

| @indiablooms | Mar 01, 2021, at 03:42 pm

Geneva/UNI: The World Health Organization (WHO) estimates that less than 10 percent of the global population have antibodies to the coronavirus, WHO Chief Scientist Soumya Swaminathan said.

"Less than 10 per cent of the world’s population actually has antibodies to this virus," Swaminathan said in a Sunday interview, released on the official WHO twitter page.

"Of course in some settings, like particularly in the very high density urban settlements, there are pockets where 50, 60 percent of the population has been exposed to the virus and has antibodies," she said.

The only way to achieve mass herd immunity is through vaccination, the WHO chief scientist stressed.

According to Swaminathan, the currently approved vaccines offer good protection against severe disease, hospitalisation and death from COVID-19. The vaccines’ effectiveness with regard to mild disease and asymptomatic coronavirus infection is still being studied.

More than 114 million coronavirus cases have been confirmed globally since the start of the pandemic last spring. According to Johns Hopkins University data, the global COVID-19 death toll stands at over 2.5 million.

Support Our Journalism

We cannot do without you.. your contribution supports unbiased journalism

IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.

Support objective journalism for a small contribution.